Filter by
Latest news from EU institutions and bodies (1110)
RSSShowing results 1 to 10
As preparations advance for the launch of the SME Fund 2026, the programme has reached a significant milestone: the 100,000th SME has received reimbursement for its intellectual property (IP) costs.
Unlocking the value of intellectual property to improve access to finance for EU businesses
January is cervical cancer awareness month! The EU4Health project EUCervScreen QA is working on updating the European clinical practice guidelines for cervical cancer prevention and is developing a European Quality Assurance (QA) scheme.
A Swedish minor has been arrested in Sweden on 23 January for his alleged involvement in a shooting outside a prison in the Netherlands, following intelligence development provided by Europol. The shooting was carried out in Alphen aan den Rijn on 16 January.
Today, the European Insurance and Occupational Pensions Authority (EIOPA) published its January 2026 Insurance Risk Dashboard.
EMA has recommended granting a marketing authorisation in the European Union for Kygevvi (doxecitine and doxribtimine) in patients with genetically confirmed thymidine kinase 2…
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 26-29 January 2026
Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its January 2026 meeting.The committee recommended…, CHMP statistics Key figures from the January 2026 CHMP meeting are represented in the graphic below. ,...
EMA has recommended extending the therapeutic indication of Zynyz (retifanlimab) to include treatment of adults with squamous cell carcinoma of the anal canal (SCAC) that cannot…